Can tamoxifen relieve motion sickness? [6]

Annals of Oncology

Volumn 16, Issue 10, 2005, Pages 1713-1714

  Gianni, L ^a   Colleoni, M ^b   Golding, J F ^c   Goldhirsch, A ^b  

^a Azienda Unità Sanitaria Locale Romagna   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GOSERELIN; TAMOXIFEN;

ADULT; BODY POSTURE; BREAST CANCER; CASE REPORT; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LETTER; MASTECTOMY; MENSTRUAL CYCLE; MOTION SICKNESS; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM;

EID: 27144498255     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdi304     Document Type: Letter

References (5)

1. Grunfeld EA, Price C, Goadsby PJ, Gresty MA. Motion sickness, migraine, and menstruation in mariners. Lancet 1998; 351: 1106.
2. Grunfeld E, Gresty MA. Relationship between motion sickness, migraine and menstruation in crew members of a 'round the world' yacht race. Brain Res Bull 1998; 47: 433-436.
3. Golding JF. A short questionnaire to assess Motion Sickness Susceptibility (MSSQ-Short): Normative values, reliability and predictive validity. International Symposium of Otoneurology, 30-31 May 2003, St. Etienne, France.
4. Nakagawa A, Uno A, Horii A et al. Fos induction in the amigdala by vestibular information during hypergravity stimulation. Brain Res 2003; 986: 114-123.
5. Rudick CN, Woolley CS. Selective estrogen receptor modulators regulate phasic activation of hippocampal CA1 pyramidal cells by estrogens. Endocrinology 2003; 144: 179-187.